WestPark Capital Reiterates Buy on Leafly Holdings, Maintains $9.18 Price Target
Leafly Holdings Analyst Ratings
Benchmark Co. Maintains Leafly(LFLY.US) With Buy Rating, Maintains Target Price $6
Leafly Holdings Analyst Ratings
WestPark Capital Reiterates Buy on Leafly Holdings, Maintains $9.18 Price Target
Benchmark Co. Remains a Buy on Leafly Holdings, Inc. (LFLY)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Petiq (PETQ), Leafly Holdings, Inc. (LFLY) and AMN Healthcare Services (AMN)
Leafly Holdings Analyst Ratings
Benchmark Maintains Buy on Leafly Holdings, Lowers Price Target to $6
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Opko Health (OPK) and Leafly Holdings, Inc. (LFLY)
Benchmark Maintains Buy on Leafly Holdings, Lowers Price Target to $3